financetom
Business
financetom
/
Business
/
Tata Power completes sale of its defence biz to Tata Advanced Systems
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Tata Power completes sale of its defence biz to Tata Advanced Systems
Nov 2, 2020 4:39 AM

Tata Power on Monday said it has completed the sale of its defence business to Tata Advanced Systems. Tata Advanced Systems is a wholly-owned subsidiary of Tata Sons. ”The sale was completed as per a Scheme of Arrangement, which was approved by the National Company Law Tribunal at Mumbai and Hyderabad in December 2019 and March 2020, respectively,” Tata Power said in a regulatory filing. The company said it is expected to receive an enterprise value of Rs 1,076 crore as an upfront payment.

Balance consideration is subject to completion of achieving certain milestones specified in the agreements, the company added. Tata Power said the sale of defence business is part of the company’s ongoing strategic plan to monetise its non-core assets and reduce overall leverage.

”The sale proceeds will help the company to reduce leverage and increase focus in the core business areas like renewable generation, distribution and new service-led businesses which will bring greater value for our shareholders,” Praveer Sinha, CEO and Managing Director, Tata Power said. Strategic Engineering Division (SED) is a non-core defence electronics division of the company, engaged in business of indigenous design, development, production, integration, supply and life cycle support of mission-critical defence systems.

The key products include manufacturing and assembling missile launchers, electronic warfare, night vision systems and gun systems. SED has three dedicated manufacturing units — Bangalore Electronic City, Vemagal in Karnataka (under construction) and an SEZ near Bengaluru (under construction).

First Published:Nov 2, 2020 1:39 PM IST

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Textron, Aeromot to Develop Drop Door for Cessna Caravan
Textron, Aeromot to Develop Drop Door for Cessna Caravan
Mar 31, 2025
01:46 PM EDT, 03/31/2025 (MT Newswires) -- Textron Aviation, a Textron ( TXT ) company, said Monday it is partnering with Aeromot Aeronaves and Motores to develop a jump/cargo drop door for Cessna Caravan aircraft at the Aeromot facility in Brazil. Textron ( TXT ) said it will provide technical and engineering data for Aeromot to develop a Brazilian Supplemental...
UWM Appoints Rami Hasani as CFO
UWM Appoints Rami Hasani as CFO
Mar 31, 2025
01:45 PM EDT, 03/31/2025 (MT Newswires) -- UWM Holdings ( UWMC ) said Monday it appointed Rami Hasani as its new chief financial officer, effective April 1. Hasani joined the company in November 2020 as vice president, financial reporting and compliance, according to UWM. Hasani succeeds Andrew Hubacker, who will become a senior adviser, the company added. Shares of UWM...
Enterprise Group Announces Stock Buyback
Enterprise Group Announces Stock Buyback
Mar 31, 2025
01:47 PM EDT, 03/31/2025 (MT Newswires) -- Enterprise Group ( ETOLF ) on Monday said the Toronto Stock Exchange has accepted its notice to launch a normal course issuer bid (NCIB). Enterprise may buy back up 5.62-million shares from April 2 for one year. The company's shares were last seen up $0.01 to $1.38, on the Toronto Stock Exchange. Price:...
AstraZeneca Says Investigational Drug Cuts LDL Cholesterol in Phase 2b Trial
AstraZeneca Says Investigational Drug Cuts LDL Cholesterol in Phase 2b Trial
Mar 31, 2025
01:55 PM EDT, 03/31/2025 (MT Newswires) -- AstraZeneca ( AZN ) said Monday its investigational drug AZD0780 combined with standard-of-care statins reduced low-density lipoprotein, or LDL, cholesterol by 50.7% at 12 weeks in a phase 2b trial, with no need for fasting or food restrictions. Among participants receiving AZD0780 30mg, 84% reached the recommended LDL-C target of under 70 mg/dL,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved